New UK Visa Rules Allow Exploited Care Workers to Leave Abusive Employers Without Losing Status
By Michael Gwarisa Thousands of migrant care workers in the United Kingdom facing exploitative or abusive working conditions could now have a crucial lifeline after the British Government changed visa rules to allow recognised victims of modern slavery to leave abusive employers without putting their immigration status at risk. The move could be particularly significant
Read More
Health Minister Warns of Cartels, Corruption in Health Sector
By Michael Gwarisa Health and Child Care Minister Dr Douglas Mombeshora has warned against the growing threat of cartels and corruption in Zimbabwe’s health sector, saying there must be no “sacred cows” when credible allegations of wrongdoing emerge. Speaking at the Ministry of Health and Child Care’s 2026 Review and Strategic Planning Meeting in Bulawayo
Read More
Drug Harm Reduction Expert Raises Red Flag Over Zimbabwe’s Militarised Rehabilitation Centres
By Michael Gwarisa Zimbabwe’s growing drug and substance abuse crisis has renewed debate over how people who use drugs are treated, with harm reduction expert Wilson Box questioning the effectiveness of militarised and highly regimented rehabilitation programmes. Box argues that drug dependence should be approached primarily as a public health issue rather than through punitive
Read More
ZCLDN Challenges Lenacapavir Rollout Over Exclusion of People Who Inject Drugs
By Michael Gwarisa Zimbabwe Civil Liberties and Drug Network (ZCLDN) has challenged the country’s rollout of lenacapavir, raising concern that people who use and inject drugs are being left out while other key populations have been identified among the priority groups for the HIV prevention technology. Speaking at a media advocacy dialogue in Harare on
Read More
The Avenues Clinic Invests US$500,000 to Modernise Critical Care Unit
By Michael Gwarisa The Avenues Clinic has invested approximately US$500,000 in upgrading its Intensive Care Unit (ICU), High Dependency Unit (HDU) and Coronary Care Unit (CCU), in a move aimed at improving patient safety, clinical outcomes and the working environment for healthcare staff. The upgrade has introduced new critical-care infrastructure and technology, including additional dialysis
Read More
“It Can Only Be God,” Says CUT Graduate As SilicaGuard Wins Cimas Healthathon
By Michael Gwarisa A digital platform designed to help screen artisanal miners for silicosis has won the third edition of the Cimas Healthathon, putting a spotlight on the potential of locally developed technology to address some of Zimbabwe’s most persistent healthcare challenges. SilicaGuard, developed by two Chinhoyi University of Technology (CUT) graduates and a medical
Read More
Pregnancy After Rape in Zimbabwe: What We Get Wrong About the Law and Survivors
By Michael Gwarisa When a woman or girl becomes pregnant after rape, the questions can come quickly. Can she legally terminate the pregnancy? Does she have to report the rape first? Does she need permission from her husband or parents? Can she simply go to a hospital? What happens if she waits too long? In
Read More
Africa CDC Assures Delegates Ahead of CPHIA as DRC Ebola Outbreak Surges
By Michael Gwarisa The Africa Centres for Disease Control and Prevention (Africa CDC) says it remains confident that the continent can safely host the Conference on Public Health in Africa (CPHIA) in Addis Ababa in November, despite the rapidly escalating Ebola outbreak in the Democratic Republic of Congo (DRC). The assurance comes as the DRC
Read More
Battle Lines Drawn as 10 Teams Vie for Cimas Healthathon 3.0 Crown in Next 24 Hours
By Michael Gwarisa HARARE-Battle lines have been drawn for the Cimas Healthathon 3.0 grand finale, with 10 teams set to go head-to-head tomorrow in a contest that organisers say could produce the next generation of digital solutions for Zimbabwe’s healthcare system. The finalists emerged from a field of 372 submissions made by innovators, start-ups, researchers,
Read More
FDA Approves Drug to Treat HIV Infection in Newborns
By Michael Gwarisa The U.S. Food and Drug Administration (FDA) has approved a new formulation of the HIV medicine dolutegravir for use in newborns from birth through four weeks of age, expanding treatment options for one of the most vulnerable groups at risk of HIV infection. The approval covers Tivicay PD tablets for oral suspension
Read More